Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

HKG:2348 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,132	905.83	811.68	577.74	730.99	471.46
Short-Term Investments	455.4	107	88.8	44.3	30.02	170.49
Trading Asset Securities	102.86	160.87	181.36	208.18	201.12	505.83
Cash & Short-Term Investments	1,691	1,174	1,082	830.22	962.12	1,148
Cash Growth	63.80%	8.49%	30.31%	-13.71%	-16.18%	-4.87%
Accounts Receivable	295.78	322	402.85	346.78	330.75	370.99
Other Receivables	-	-	-	20.8	-	-
Receivables	295.78	322	402.85	367.58	330.75	370.99
Inventory	235.66	211.11	241.75	203.48	246.03	180.76
Prepaid Expenses	8.53	13.4	14.99	15.5	9.75	15.65
Other Current Assets	-	-	2.58	94.26	0.07	-
Total Current Assets	2,231	1,720	1,744	1,511	1,549	1,715
Property, Plant & Equipment	1,236	1,217	1,301	1,143	781.95	596.3
Long-Term Investments	20	20	25.35	87.25	98.67	77.44
Goodwill	241.16	241.16	241.16	241.16	241.16	241.16
Other Intangible Assets	303.11	160.31	109.48	97.99	36.18	24.49
Long-Term Deferred Tax Assets	3.46	18.98	6.86	5.75	6.53	6.64
Long-Term Deferred Charges	-	128	185.54	189.03	170.54	125.17
Other Long-Term Assets	10.24	10.3	7.56	14.36	20	-
Total Assets	4,045	3,623	3,673	3,340	2,904	2,786
Accounts Payable	189.42	162.16	224.07	143.21	157.61	156.76
Accrued Expenses	-	108.27	171.28	156.94	125.79	142.91
Short-Term Debt	182.55	120.06	6.43	21.01	-	216.78
Current Portion of Leases	1.37	0.36	1.53	0.98	0.92	0.07
Current Income Taxes Payable	14.44	45.23	8.65	15.5	9.3	5.81
Current Unearned Revenue	-	17.9	29.66	14.45	8.47	15.46
Other Current Liabilities	268.08	214.96	490.43	345.01	177.81	81.54
Total Current Liabilities	655.85	668.94	932.06	697.1	479.91	619.32
Long-Term Leases	4.17	0.1	0.44	1.53	2.03	2.84
Long-Term Unearned Revenue	-	-	0.3	0.6	0.9	1.2
Long-Term Deferred Tax Liabilities	102.92	94.38	89.98	66.87	61.72	66.47
Other Long-Term Liabilities	10.5	-	-	175.6	175.6	70.24
Total Liabilities	773.44	763.43	1,023	941.7	720.14	760.08
Common Stock	80.46	80.46	80.39	80.37	81.07	82.87
Additional Paid-In Capital	104.57	104.41	103.09	102.7	100.18	100.18
Retained Earnings	3,051	2,649	2,436	2,174	1,940	1,796
Treasury Stock	-	-	-	-	-0.43	-0.16
Comprehensive Income & Other	32.15	21.24	22.51	23.2	49.26	47.24
Total Common Equity	3,268	2,855	2,642	2,381	2,171	2,026
Minority Interest	3.12	4.58	7.91	17.15	13.09	0.68
Shareholders' Equity	3,271	2,859	2,650	2,398	2,184	2,026
Total Liabilities & Equity	4,045	3,623	3,673	3,340	2,904	2,786
Total Debt	188.1	120.53	8.41	23.52	2.95	219.68
Net Cash (Debt)	1,502	1,053	1,073	806.7	959.17	928.1
Net Cash Growth	50.46%	-1.89%	33.06%	-15.90%	3.35%	-23.08%
Net Cash Per Share	1.00	0.70	0.71	0.53	0.62	0.59
Filing Date Shares Outstanding	1,500	1,500	1,499	1,498	1,505	1,553
Total Common Shares Outstanding	1,500	1,500	1,499	1,498	1,505	1,553
Working Capital	1,575	1,051	811.94	813.93	1,069	1,096
Book Value Per Share	2.18	1.90	1.76	1.59	1.44	1.30
Tangible Book Value	2,724	2,453	2,291	2,042	1,893	1,760
Tangible Book Value Per Share	1.82	1.64	1.53	1.36	1.26	1.13
Buildings	-	584.74	531.28	243.42	309.25	309.56
Machinery	-	485.74	721.4	624.16	749.76	723.81
Construction In Progress	-	356.9	495.14	675.2	204.8	26.95
Leasehold Improvements	-	6.66	6.64	6.59	5.98	0.11

Source: S&P Capital IQ. Standard template. Financial Sources.